Generation Bio Co.

NASDAQ:GBIO

2.16 (USD) • At close November 4, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Revenue 4.0914.0592.8782.1460.8800000000000000000
Cost of Revenue 1.2631.3121.9661.2931.3151.331.34617.2281.2231.1971.1651.1731.131.06400000000
Gross Profit 2.8282.7470.9120.853-0.435-1.33-1.346-17.228-1.223-1.197-1.165-1.173-1.13-1.06400000000
Gross Profit Ratio 0.6910.6770.3170.397-0.49400000000000000000
Reseach & Development Expenses 15.12513.02327.92321.86221.8322221.60721.19228.36525.55421.84721.99122.65618.75316.37415.30813.45613.39412.73113.44712.23711.719
General & Administrative Expenses 9.51510.42813.37611.64112.96712.86613.08111.47710.1169.799.0999.6678.1866.9027.9715.6614.3084.6423.4272.8863.0982.757
Selling & Marketing Expenses -0.1-0.31100000000000000000000
SG&A 9.41510.11713.37611.64112.96712.86613.08111.47710.1169.799.0999.6678.1866.9027.9715.6614.3084.6423.4272.8863.0982.757
Other Expenses 1.49756.9300000000000000000000
Operating Expenses 24.5423.1441.29933.50334.79934.86634.68832.66938.48135.34430.94631.65830.84225.65524.34520.96917.76418.03616.15816.33315.33514.476
Operating Income -21.712-20.393-38.421-31.357-33.919-34.866-34.688-32.669-38.481-35.344-30.946-31.658-30.842-25.655-24.345-20.969-17.764-18.036-16.158-16.333-15.335-14.476
Operating Income Ratio -5.307-5.024-13.35-14.612-38.54400000000000000000
Total Other Income Expenses Net 1.28-54.1483.2353.0912.8532.7722.2831.3630.5520.3450.003-0.1970.0510.0930.1190.120.0330.3190.0950.2050.3030.382
Income Before Tax -20.432-74.541-35.186-28.266-31.066-32.094-32.405-31.306-37.929-34.999-30.943-31.855-30.791-25.562-24.226-20.849-17.731-17.717-16.063-16.128-15.032-14.094
Income Before Tax Ratio -4.994-18.364-12.226-13.171-35.30200000000000000000
Income Tax Expense 01.2695.395-1.2931.193-4.102-2.283-0-0.552-0.345-1.165000-0.991-0.939000000
Net Income -20.432-74.541-35.186-28.266-31.066-27.992-30.122-31.306-37.377-34.654-30.943-31.855-30.791-25.562-24.226-20.849-17.731-17.717-16.063-16.128-15.032-14.094
Net Income Ratio -4.994-18.364-12.226-13.171-35.30200000000000000000
EPS -0.31-1.12-0.53-0.43-0.47-0.46-0.51-0.53-0.65-0.61-0.55-0.56-0.55-0.46-0.53-0.46-1.5-0.43-0.51-0.51-0.48-0.45
EPS Diluted -0.31-1.12-0.53-0.43-0.47-0.46-0.51-0.53-0.65-0.61-0.54-0.56-0.55-0.46-0.53-0.46-1.5-0.43-0.51-0.51-0.48-0.45
EBITDA -20.449-19.081-37.096-31.357-32.604-34.866-34.688-31.305-37.258-34.147-30.946-30.485-29.712-24.591-24.345-20.969-16.939-17.359-15.479-15.673-14.98-14.306
EBITDA Ratio -4.999-4.701-12.89-14.612-37.0500000000000000000